These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 9458208

  • 21. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A, Bellissimo S, Scotto di Uccio F, Vigorito F, Moscato F, Tozzi N, Di Donato M, Citro R, Stisi S, Scherillo M.
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [Abstract] [Full Text] [Related]

  • 22. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, Denton CP.
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K.
    J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
    [Abstract] [Full Text] [Related]

  • 24. Establishment and partial validation of a patient skin self-assessment questionnaire in systemic sclerosis.
    Nagy Z, Bálint Z, Farkas H, Radics J, Kumánovics G, Minier T, Varjú C, Czirják L.
    Rheumatology (Oxford); 2009 Mar; 48(3):309-14. PubMed ID: 19181657
    [Abstract] [Full Text] [Related]

  • 25. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
    Davies CA, Jeziorska M, Freemont AJ, Herrick AL.
    Hum Pathol; 2006 Feb; 37(2):190-7. PubMed ID: 16426919
    [Abstract] [Full Text] [Related]

  • 26. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
    Allanore Y, Borderie D, Lemaréchal H, Cherruau B, Ekindjian OG, Kahan A.
    J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Plasmapheresis therapy in systemic sclerosis].
    Szúcs G, Szamosi S, Aleksza M, Veres K, Soltész P.
    Orv Hetil; 2003 Nov 09; 144(45):2213-7. PubMed ID: 14686006
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.
    Akhmetshina A, Beer J, Zwerina K, Englbrecht M, Palumbo K, Dees C, Reich N, Zwerina J, Szucs G, Gusinde J, Nevskaya T, Distler O, Kerjaschki D, Schett G, Distler JH.
    Arthritis Rheum; 2010 May 09; 62(5):1513-22. PubMed ID: 20155824
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
    Del Rosso A, Distler O, Milia AF, Emanueli C, Ibba-Manneschi L, Guiducci S, Conforti ML, Generini S, Pignone A, Gay S, Madeddu P, Matucci-Cerinic M.
    Ann Rheum Dis; 2005 Mar 09; 64(3):382-7. PubMed ID: 15708892
    [Abstract] [Full Text] [Related]

  • 37. Pupillocynetic activity of substance P in systemic sclerosis.
    Del Rosso A, Bertinotti L, Pietrini U, Messori A, Fanciullacci M, Casale R, Giacomelli R, Generini S, Sicuteri R, Pignone A, Cozzi F, Matucci-Cerinic M.
    J Rheumatol; 2003 Jun 09; 30(6):1231-7. PubMed ID: 12784395
    [Abstract] [Full Text] [Related]

  • 38. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP, Diot E, Clerson P, Dupuis-Siméon F, Hachulla E, Hatron PY, Constans J, Cirstéa D, Farge-Bancel D, Carpentier PH.
    J Rheumatol; 2009 Jul 09; 36(7):1470-6. PubMed ID: 19487271
    [Abstract] [Full Text] [Related]

  • 39. Digital thermal hyperaemia impairment does not relate to skin fibrosis or macrovascular disease in systemic sclerosis.
    Salvat-Melis M, Carpentier PH, Minson CT, Boignard A, McCord GR, Paris A, Moreau-Gaudry A, Cracowski JL.
    Rheumatology (Oxford); 2006 Dec 09; 45(12):1490-6. PubMed ID: 16705051
    [Abstract] [Full Text] [Related]

  • 40. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.
    Paradiso M, Di Franco M, Musca A, Basili S, Riccieri V, Paoletti V, De Matteis A, Mammarella A.
    J Rheumatol; 2002 Jul 09; 29(7):1388-92. PubMed ID: 12136893
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.